There is definitely good news on the horizon, just watch the share price, that has always been a valid indicator in the past. There were alot of buyers at .70 cents today. As we all know, Abbott has applied for a patent on Recaf on their Architect system for lung cancer. Probably, because there are no valid markers for lung cancer and this will get the attention of medical community. We all focus on prostrate, but forget this is a universal marker.
News 
Market Data 
Discover 
